PenRad Announces PenAlert

My Subscriptions

Payment Confirmation

Transaction Failed

Your transaction failed, please try again or contact site support.

As various regulations evolve and malpractice rates increase, imaging providers need to take a proactive approach to notify patients directly of any significant abnormality or normal result. Pennsylvania (PA112) already has set a precedent, adding burden and liability concerns for radiologists and referring physicians.

PenRad, the Radiologists preferred mammography and LDCT reporting and tracking system, has created PenAlert in direct response by expanding the footprint to all diagnostic imaging. PenAlert automates patient notification with zero change to Radiologist workflow, while aiding in practice liability management. This enhances patient satisfaction, tracking patients and findings to resolution, and assists the referring physician with direct patient result notification. Currently, PenRad’s technology provides these benefits to more than 10,000,000 exams per year, in mammography alone.  PenAlert represents a move to provide these benefits to all diagnostic imaging and millions of additional exams.

PenAlert uses machine learning intelligence to extract key findings from the radiologist’s narrative report and catalogs the exam and findings. The patient exam letter describes findings and concerns, or normal results can be communicated as well, all in patient terminology. This automation inserts referring physician contact info, sub-specialty care specialists (if applicable), future recommended imaging, and more. All this detail is in the patient’s preferred language, with automated delivery via; email, mail, an existing Portal or our PenXpress patient portal.

Other features include recall letters, management reports, analytics for findings and outcomes. PenAlert facilitates compliance with key CMS quality payment program requirements and increases the opportunity to report compliance and best practices with Medicare’s Merit-based Incentive Payment System (MIPS).

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.